Surface and Interacellular Targets of Acute Myeloid Leukemia Therapy Detectable at Leukemic Stem Cell level
Journal Title: Haematology International Journal - Year 2018, Vol 2, Issue 1
Abstract
For over 50 years investigators have considered a malignant stem cell as the potential origin of and a key therapeutic target for acute myeloid leukaemia (AML) and other forms of cancer [1]. Leukaemic stem cells (LSCs) have been identified in acute myeloid leukaemia (AML). Similar to haemopoietic stem cells, these LSCs are able to self-renew, differentiate, and proliferate extensively. Recent studies suggest that LSCs are critical for the initiation and maintenance of leukaemia. Exciting new insights into the fundamental underpinnings of LSCs are now being made in an era in which drug development pipelines offer the potential to specifically target pathways of significance. This mini review will describe the possible targets expressed on the surface of AML, the intracellular targets and the novel molecular and flow cytometry methodologies being used to particularly ablate the LSC population.
Authors and Affiliations
Adhra Al-Mawali
Keywords
Related Articles
- EP ID EP291048
- DOI -
- Views 116
- Downloads 0
Cost-Effectiveness of Idelalisib-Rituximab for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia
1.1. Background: A significant survival prolongation was recently reported by adding idelalisib to rituximab (IR) compared with rituximab (R) in the treatment of relapsed/refractory chronic lymphocytic leukemia (CLL). No...
MicroRNA 221 Expression by Leukocytes Correlates with the Clinical Severity of Sickle Cell Disease
1.1. Objective: The severity of sickle cell disease (SCD) increases with neutrophil count and expression of adhesion molecules by leukocytes. Intercellular adhesion molecule one (ICAM-1) on vascular endothelium mediates...
Differential Correlation between Foetal Haemoglobin and Full Blood Count Based on Inherited Haemoglobin Type; A Cross-Sectional Study in Cape Coast, Ghana
1.1. Background: Foetal haemoglobin (Hb F) has been shown to modulate the severity of sickle cell anaemia (SCA). However, there is scarcity of data on the impact of Hb F levels in other inherited haemoglobin variants. Th...
Surface and Interacellular Targets of Acute Myeloid Leukemia Therapy Detectable at Leukemic Stem Cell level
For over 50 years investigators have considered a malignant stem cell as the potential origin of and a key therapeutic target for acute myeloid leukaemia (AML) and other forms of cancer [1]. Leukaemic stem cells (LSCs) h...
Fatal Case of Haemophagocytic Syndrome Associated With Infection of Plasmodium Falciparum
Haemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory condition which can occur as a primary syndrome (genetic in origin) or arise secondary to infectious, rheumatologic, malignant or metabolic disorders. HLH...